# FDA Inspection 1206365 - Netaji Subhash Chandra Bose Cancer Hospital - April 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/netaji-subhash-chandra-bose-cancer-hospital/5273454f-d4f3-4d5f-adc2-e5d0d0fb8612
Source feed: FDA_Inspections

> FDA Inspection 1206365 for Netaji Subhash Chandra Bose Cancer Hospital on April 21, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206365
- Company Name: Netaji Subhash Chandra Bose Cancer Hospital
- Inspection Date: 2023-04-21
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1067106 - 2018-08-16](https://www.keypedia.com/records/fda_inspections/netaji-subhash-chandra-bose-cancer-hospital/828486c3-bdcd-49dc-95ee-07e46a8be24c)

Company: https://www.keypedia.com/companies/netaji-subhash-chandra-bose-cancer-hospital/5c8c8b13-5106-46dd-ab56-1144455f7997

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c